Management of malignant pleural effusion
- 1 June 1998
- journal article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 28 (3) , 394-396
- https://doi.org/10.1111/j.1445-5994.1998.tb01972.x
Abstract
Malignant pleural effusion is a frequent cause of morbidity in cancer patients. Pleural aspiration relieves dyspnoea usually only for a matter of days, and if the tumour type is not chemosensitive, some form of pleurodesis is commonly required. Tube thoracostomy is widely used to achieve pleural drainage prior to attempting pleurodesis by instillation of a variety of 'sclerosants'. Recently thoracoscopic instillation of talc has been advocated and some authors report high rates of fluid control. Randomised trials comparing this approach compared to tube thoracostomy and chemical pleurodesis are required.Keywords
This publication has 10 references indexed in Scilit:
- How should cancer presenting as a malignant pleural effusion be managed?British Journal of Cancer, 1996
- Management of recurrent malignant pleural effusions. The complementary role of talc pleurodesis and pleuroperitoneal shuntingCancer, 1995
- Intrapleural Therapy for Malignant Pleural EffusionsChest, 1991
- Pleuroperitoneal shunt for recurrent malignant pleural effusions.Thorax, 1990
- Intrapleural Natural Beta Interferon in the Treatment of Malignant Pleural EffusionsOncology, 1988
- Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.Thorax, 1980
- Carcinomatous involvement of the pleuraThe American Journal of Medicine, 1977
- Indications for pleurectomy in malignant effusionCancer, 1975
- The treatment of malignant pleural effusionsCancer, 1974
- Intrapleural chemotherapy for effusion from metastatic breast carcinomaCancer, 1970